Work

Updated Results and Correlative Analysis: Autologous CD30.CAR-T-Cell Therapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (CHARIOT Trial)

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-158869

Authors: Sairah Ahmed, Ian W. Flinn, Matthew Mei, Peter A. Riedell, Philippe Armand, Natalie S. Grover, Renu Balyan, Cliff Ding, Aung Myo, Ivan D. Horak, Helen E. Heslop

Institutions: The University of Texas MD Anderson Cancer Center, Tennessee Oncology, City Of Hope National Medical Center, City of Hope, University of Chicago, Dana-Farber Cancer Institute, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Tessa Therapeutic (Singapore), Baylor College of Medicine

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310089922

FWCI: 1.658

Cites:

Cited by: 20

Related to: 10